Approved Use: Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.

IMPORTANT SAFETY INFORMATION

Who should not use Aimovig®?

Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®.

Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig®?

Aimovig® may cause serious side effects, including:

  • Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.

  • Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation.

  • High blood pressure. High blood pressure or worsening of high blood pressure can happen after receiving Aimovig®. Contact your healthcare provider if you have an increase in blood pressure.

The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation.

These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for the full Prescribing Information and Patient Product Information.

APPROVED USE

Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.

join the AIM Network

sign up and help inspire others

Just as you may find helpful information from hearing about other people’s experiences with migraine, your journey may be able to empower others in the same way.

That’s exactly what the AIM Network is all about.

The AIM Network is a voluntary program for people currently taking Aimovig®.

Become an AIM Network Member to help inspire others on their treatment journey.* Sharing the moments that make up your story, whether those are the tough times or the days when you’re able to say “I am here,“ can be motivating both for yourself and those considering Aimovig®.

After you join the AIM Network, we’ll check in with you about different ways you can share your story. This could be through photos, videos, or in written form. And, depending on your interest and qualifications, you may also be invited to participate in activities like photoshoots or speaking events.

*Joining this network is strictly voluntary. Your participation will not affect your medical care.

Aimovig is indicated for the preventive treatment of migraine in adults and reduces monthly migraine days.

Ready to get started?


Answer a few short questions to join the AIM Network

do all of these apply to you?


  • I currently treat my migraine with Aimovig® (erenumab-aooe)
  • I began taking Aimovig® when I was at least 18 years of age
  • I live in the United States
  • I am interested in sharing photos, videos, and quotes for use by Aimovig® in educational or promotional materials




Unfortunately, you haven't qualified for the AIM Network. However, we'd love for you to join our growing community of patients and advocates on Facebook and Instagram.

join us!

 

tell us about yourself

step 1 of 3


*Required Information


Please enter a first name
Please enter a last name
Please select month
Please select day
Please select year

"We're sorry—you must be 18 years or older to join the AIM Network

Please enter a valid email address
The Email and Confirm Email fields do not match
Please enter a last name
Please enter a last name
Please enter a last name
Please enter a city
Please select state
Please enter valid Zip Code
Please enter phone number
Please enter phone type
Please check this box
Please check consent
Required

Gender*

Before taking Aimovig, how many days per month did you experience migraine?

Note: These are the total number of days you were impacted by migraine, not the number of migraine attacks

Next up, find out how you can participate in the AIM Network

step 1 of 3

please review the patient authorization information:

step 3 of 3


Patient Authorization

I authorize Amgen and Novartis and its contractors and business partners ("Amgen" and "Novartis") to use and/or disclose my personal information, including my personal health information, for the following purposes: To operate, administer, enroll me in and/or continue my participation in Amgen's and Novartis's AIM Network and related activities; To provide me with informational and promotional materials relating to Amgen and Novartis products and services, and/or my condition or treatment; and/or to improve, develop, and evaluate products, services, materials and programs related to my condition or treatment. I consent to Amgen and Novartis contacting me about the AIM Network using the information provided in this form, including by calls made using an autodialer or prerecorded voice. I further understand that the AIM Network and additional informational and marketing communications related to my condition and treatment are optional and free services. I do not have to sign this authorization and this authorization in no way affects my right to obtain any medications. For further information about Amgen's and Novartis's privacy practices please see https://www.migraineprivacypolicy.com. By clicking 'Submit your info,' I agree to enroll in the AIM Network, and to receive marketing communications from Amgen and Novartis. I can opt-out at any time.

I consent to being contacted by the AIM Network to learn more about sharing my story and/or learn about opportunities to participate in branded activities.

Please check
Nevermind, I do not wish to participate



You're all set!

contact us here 1-833-AIMOVIG (1-833-246-6844)
8 AM-9 PM ET, Mon-Fri

IMPORTANT SAFETY INFORMATION

Who should not use Aimovig®?

Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®.

Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig®?

Aimovig® may cause serious side effects, including:

  • Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.

  • Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation.

  • High blood pressure. High blood pressure or worsening of high blood pressure can happen after receiving Aimovig®. Contact your healthcare provider if you have an increase in blood pressure.

The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation.

These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for the full Prescribing Information and Patient Product Information.

APPROVED USE

Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.